Apostatin-1
CAS No. 2559703-06-7
Apostatin-1 ( Apt-1 )
产品货号. M24150 CAS No. 2559703-06-7
Apostatin-1 是一种新型 TRADD 抑制剂。 Apostatin-1 可以与 TRADD N 端 TRAF2 结合域上的口袋结合。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥356 | 有现货 |
|
| 5MG | ¥583 | 有现货 |
|
| 10MG | ¥988 | 有现货 |
|
| 25MG | ¥2001 | 有现货 |
|
| 50MG | ¥3216 | 有现货 |
|
| 100MG | ¥4771 | 有现货 |
|
| 500MG | ¥10368 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Apostatin-1
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Apostatin-1 是一种新型 TRADD 抑制剂。 Apostatin-1 可以与 TRADD N 端 TRAF2 结合域上的口袋结合。
-
产品描述Apostatin-1 is a novel TRADD inhibitor. Apostatin-1 can bind to a pocket on the N-terminal TRAF2 binding domain of TRADD.
-
体外实验Western Blot Analysis Cell Line:SH-SY5Y, HeLa, HT-29, and Jurkat cells Concentration:10 μM Incubation Time:6 h Result:Effectively induced autophagy by LC3 II induction and p62 reduction.
-
体内实验Animal Model:Wild-type mice (n = 10, male, 8 weeks of age, systemic inflammation mouse model)Dosage:20 mg/kgAdministration:IP, onceResult:Reduced expression of the TNF-induced inflammatory target gene products, NOS and COXII27, and of inflammatory cytokines in cells stimulated with pathogen-associated molecular patterns, including interferon γ (IFNγ), lipopolysaccharide (LPS), Pam3CSK4 (a synthetic bacterial lipopeptide), and muramyl dipeptide (MDP). Showed increased survival following intravenous delivery of TNF, a mouse model of systemic inflammation.
-
同义词Apt-1
-
通路Others
-
靶点Other Targets
-
受体TRADD
-
研究领域——
-
适应症——
化学信息
-
CAS Number2559703-06-7
-
分子量345.5
-
分子式C19H27N3OS
-
纯度>98% (HPLC)
-
溶解度DMSO:65mg/ml(188.13mM; need ultrasonic); Ethanol:9mg/ml(26.06mM; need ultrasonic)
-
SMILESO=C(NC1CCCCCC1)C(C2=CC=CC=C2)SC3=NCCN3C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Xu D , Zhao H , Jin M , et al. Modulating TRADD to restore cellular homeostasis and inhibit apoptosis[J]. Nature, 2020, 587(7832):1-6.
产品手册
关联产品
-
Thonzylamine hydroch...
Thonzylamine Hydrochloride 是一种抗胆碱能药和抗组胺药,用作止痒剂。
-
Niraparib Tosylate M...
Niraparib 是 Tesaro 开发的一种口服活性小分子 PARP 抑制剂,用于治疗卵巢癌。
-
AMDE-1
AMDE-1 是一种自噬活性调节剂,通过以 Atg5 依赖性方式触发自噬、将 Atg16 招募到自噬体前位点并引起 LC3 脂化来发挥作用。
021-51111890
购物车()
sales@molnova.cn

